The estrous cycle moderates the food and body weight suppressive effects of glucagon‐like peptide‐1 receptor agonism
GLP-1RAs administered in P/E lead to significantly greater body weight loss via reduction in food intake. Collectively, these data may have translational implications for the timing of GLP-1RA administration across the menstrual cycle.
Authors
- Benjamin C. Reiner (ORCID: https://orcid.org/0000-0001-7796-587X)
- Matthew R. Hayes (ORCID: https://orcid.org/0000-0001-9782-6551)
- Sarah V. Applebey (ORCID: https://orcid.org/0000-0002-8162-8785)
- Allison G. Xiao
Institutions
- University of Pennsylvania (US)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1111/dom.70177
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59